Forum > Topic Details

Which Is The Primary Mechanism Of Vilitra 20 Action In Treating ED?

Which Is The Primary Mechanism Of Vilitra 20 Action In Treating ED?

by Robert Tanser (Posts: 0) » about 29 days ago

Vilitra 20 contains Vardenafil, a medication classified as a phosphodiesterase type 5 (PDE5) inhibitor. The primary mechanism of action of Vilitra 20 in treating erectile dysfunction (ED) involves its effects on the smooth muscle cells in the walls of blood vessels in the penis. Here’s how it works:

Inhibition of PDE5: Vardenafil in Vilitra 20 inhibits the enzyme PDE5, which is responsible for breaking down cyclic guanosine monophosphate (cGMP). cGMP is a molecule that promotes relaxation of smooth muscle cells in the blood vessels of the penis, allowing them to dilate and increase blood flow.

Enhanced Blood Flow: By inhibiting PDE5, Vilitra 20 mg  increases the levels of cGMP in the penis. This leads to relaxation and dilation of the blood vessels, particularly those supplying the corpus cavernosum of the penis, which is crucial for achieving and maintaining an erection.

Erection Response: When a man is sexually aroused, nitric oxide is released from nerve endings in the penis. Nitric oxide stimulates the production of cGMP, which in turn relaxes the smooth muscles and allows blood to flow into the erectile tissues, resulting in an erection.

Sustained Erection: Vilitra 20 helps sustain the erection by maintaining elevated levels of cGMP in the penis. This allows for prolonged blood flow during sexual stimulation, which is essential for maintaining rigidity and achieving satisfactory sexual performance.

Key Points to Remember:

Stimulation Required: Vilitra 20 enhances the natural response to sexual stimulation. It does not directly cause an erection without sexual arousal.

Duration of Action: The effects of Vardenafil typically last for about 4 to 5 hours, providing a suitable window for sexual activity.

Safety Considerations: It's important for individuals to use Vilitra 20 only as prescribed by a healthcare provider to ensure safety and effectiveness, especially considering potential interactions with other medications or underlying health conditions.

In conclusion, Vilitra 20's primary mechanism of action involves inhibiting PDE5, leading to increased levels of cGMP in the penis. This results in improved blood flow, which helps men with ED achieve and maintain erections sufficient for satisfactory sexual activity.


(0) Answer(s)